Jacob Riehm

1.3k total citations
25 papers, 916 citations indexed

About

Jacob Riehm is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jacob Riehm has authored 25 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jacob Riehm's work include Acute Myeloid Leukemia Research (2 papers), Cancer Research and Treatments (2 papers) and Clinical Nutrition and Gastroenterology (2 papers). Jacob Riehm is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Cancer Research and Treatments (2 papers) and Clinical Nutrition and Gastroenterology (2 papers). Jacob Riehm collaborates with scholars based in United States, China and Japan. Jacob Riehm's co-authors include Madelyn Kahana, Paul E. Wischmeyer, Rachel L. Wolfson, Jennifer Liedel, Lawrence J. Gottlieb, James P. Lynch, Mark W. Musch, Eugene B. Chang, Ravi Salgia and Kristen D. Singleton and has published in prestigious journals such as Blood, Gastroenterology and Molecular and Cellular Biology.

In The Last Decade

Jacob Riehm

24 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob Riehm United States	13	319	306	292	158	154	25	916
Chandrashekhara Manithody United States	22	288 0.9×	82 0.3×	234 0.8×	91 0.6×	68 0.4×	61	1.3k
Mien T.X. Nguyen United States	13	575 1.8×	150 0.5×	151 0.5×	56 0.4×	42 0.3×	14	1.0k
Richard Sparla Germany	10	383 1.2×	131 0.4×	144 0.5×	78 0.5×	37 0.2×	21	925
Morgan L. Locy United States	18	428 1.3×	541 1.8×	48 0.2×	110 0.7×	62 0.4×	22	1.1k
James D. Calore United States	16	232 0.7×	381 1.2×	70 0.2×	164 1.0×	106 0.7×	28	936
Yongtao Xiao China	21	490 1.5×	144 0.5×	105 0.4×	82 0.5×	220 1.4×	61	1.3k
Preeti Kanikarla Marie United States	16	260 0.8×	80 0.3×	85 0.3×	191 1.2×	224 1.5×	28	803
Arijit Biswas Germany	20	242 0.8×	404 1.3×	83 0.3×	166 1.1×	32 0.2×	96	1.3k
Bhupesh Singla United States	19	303 0.9×	66 0.2×	70 0.2×	134 0.8×	110 0.7×	52	940
Wulf Tonnus Germany	13	642 2.0×	305 1.0×	63 0.2×	40 0.3×	99 0.6×	19	1.0k

Countries citing papers authored by Jacob Riehm

Since Specialization

Citations

This map shows the geographic impact of Jacob Riehm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Riehm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Riehm more than expected).

Fields of papers citing papers by Jacob Riehm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Riehm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Riehm. The network helps show where Jacob Riehm may publish in the future.

Co-authorship network of co-authors of Jacob Riehm

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Riehm. A scholar is included among the top collaborators of Jacob Riehm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Riehm. Jacob Riehm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Phillips, Darren C., Cory Alvey, Justin P. Ingram, et al.. (2024). Abbv-453: A Highly Potent and Selective Next Generation Small Molecule Inhibitor of BCL-2. Blood. 144(Supplement 1). 4966–4966. 1 indexed citations

Plotnik, Joshua P., Irene Lee, Jacob Riehm, et al.. (2024). MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer. Molecular Cancer Research. 22(8). 689–698.

Refici, Marion, Ziping Yang, Jacob Riehm, et al.. (2022). Abstract 5339: BCL2A1 is expressed in myelofibrosis specimens and JAK2-mutated UKE-1 cells, yet does not inhibit synergistic cell killing by BCL-XL inhibitor navitoclax plus JAK1/2 inhibitors, including ruxolitinib. Cancer Research. 82(12_Supplement). 5339–5339. 2 indexed citations

Chyla, Brenda, Jason G. Harb, Christine Mantis, et al.. (2019). Response to Venetoclax in Combination with Low Intensity Therapy (LDAC or HMA) in Untreated Patients with Acute Myeloid Leukemia Patients with IDH, FLT3 and Other Mutations and Correlations with BCL2 Family Expression. Blood. 134(Supplement_1). 546–546. 16 indexed citations

Riehm, Jacob, Lijun Wang, Ghanashyam D. Ghadge, et al.. (2018). Poloxamer 188 decreases membrane toxicity of mutant SOD1 and ameliorates pathology observed in SOD1 mouse model for ALS. Neurobiology of Disease. 115. 115–126. 11 indexed citations

Shi, Puyu, You-Take Oh, Guojing Zhang, et al.. (2016). Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. Cancer Letters. 380(2). 494–504. 147 indexed citations

Lennon, Frances E., Gianguido C. Cianci, Rajani Kanteti, et al.. (2016). Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma. Scientific Reports. 6(1). 24578–24578. 32 indexed citations

Kanteti, Rajani, Jacob Riehm, Frances E. Lennon, et al.. (2016). PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma. Scientific Reports. 6(1). 32992–32992. 21 indexed citations

Shi, Puyu, You-Take Oh, Guojing Zhang, et al.. (2016). Abstract 2105: c-Met hyperactivation is an universal resistance mechanism to both first and third generation EGFR inhibitors. Cancer Research. 76(14_Supplement). 2105–2105. 1 indexed citations

10.

Kanteti, Rajani, Essam El‐Hashani, Jacob Riehm, et al.. (2015). C. elegansand mutants with chronic nicotine exposure as a novel model of cancer phenotype. Cancer Biology & Therapy. 17(1). 91–103. 4 indexed citations

11.

Allen, Michael J., Rajani Kanteti, Jacob Riehm, Essam El‐Hashani, & Ravi Salgia. (2015). Whole-animal mounts of Caenorhabditis elegans for 3D imaging using atomic force microscopy. Nanomedicine Nanotechnology Biology and Medicine. 11(8). 1971–1974. 8 indexed citations

12.

Mirzapoiazova, Tamara, Frances E. Lennon, Bolot Mambetsariev, et al.. (2015). Extracellular Vesicles from Caveolin-Enriched Microdomains Regulate Hyaluronan-Mediated Sustained Vascular Integrity. International Journal of Cell Biology. 2015. 1–11. 18 indexed citations

13.

Dho, So Hee, Benjamin E. Deverman, Scott R. Manson, et al.. (2013). Control of Cellular Bcl-xL Levels by Deamidation-Regulated Degradation. PLoS Biology. 11(6). e1001588–e1001588. 28 indexed citations

14.

Ropeleski, Mark J., Jacob Riehm, Kathy A. Baer, Mark W. Musch, & Eugene B. Chang. (2005). Anti-apoptotic Effects of L-Glutamine—Mediated Transcriptional Modulation of the Heat Shock Protein 72 During Heat Shock. Gastroenterology. 129(1). 170–184. 47 indexed citations

15.

Zhang, Zhongqiu, Scott R. Manson, Jacob Riehm, et al.. (2005). A moderate reduction of Bcl-xL expression protects against tumorigenesis; however, it also increases susceptibility to tissue injury. Oncogene. 24(47). 7120–7124. 3 indexed citations

16.

Singleton, Kristen D., et al.. (2003). Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia‐reperfusion injury. Journal of Parenteral and Enteral Nutrition. 27(6). 396–403. 76 indexed citations

17.

Shao, Zuoyi, et al.. (2003). Glutamine preserves cardiomyocyte viability and enhances recovery of contractile function after ischemia‐reperfusion injury. Journal of Parenteral and Enteral Nutrition. 27(2). 116–122. 45 indexed citations

18.

Wischmeyer, Paul E., Jacob Riehm, Kristen D. Singleton, et al.. (2002). Glutamine attenuates tumor necrosis factor-α release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition. 19(1). 1–6. 106 indexed citations

19.

Wischmeyer, Paul E., James P. Lynch, Jennifer Liedel, et al.. (2001). Glutamine administration reduces Gram-negative bacteremia in severely burned patients: A prospective, randomized, double-blind trial versus isonitrogenous control. Critical Care Medicine. 29(11). 2075–2080. 233 indexed citations

20.

Riehm, Jacob, et al.. (2001). GLUTAMINE ATTENUATES TNF-ALPHA RELEASE AND ENHANCES HSP 72 EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS POST-ENDOTOXIN ADMINISTRATION. Shock. 15(Supplement). 82–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact